Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasospasm-induced myocardial infarction with sumatriptan

L Mueller1, R M Gallagher, C A Ciervo

  • 1Department of Family Practice, University Headache Center, Moorestown, NJ 08057, USA.

Headache
|May 1, 1996
PubMed
Summary

Sumatriptan, a migraine treatment, can cause chest pain. This case suggests it may induce coronary vasospasm and myocardial infarction, even in patients with normal cardiovascular evaluations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Psychopharmacology·2026
Same author

The role of body composition and visceral fat in osteoporosis subtype differentiation: Insights from bioelectrical impedance analysis.

Journal of orthopaedics·2025
Same author

Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.

European journal of immunology·2025
Same author

Low androgen signaling rescues genome integrity with innate immune response by reducing fertility in humans.

Cell death & disease·2024
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023
Same author

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Sumatriptan is a widely used abortive medication for migraine headaches.
  • Chest pain is a known side effect, occurring in 3-7.9% of patients, with an unclear cardiac mechanism.
  • Rare cardiac events like myocardial infarction have been anecdotally linked to sumatriptan use.

Observation:

  • A 56-year-old female migraine patient experienced a myocardial infarction shortly after sumatriptan administration.
  • The patient had a normal cardiovascular evaluation prior to the event.
  • Cardiac catheterization post-myocardial infarction revealed no underlying cardiovascular disease.

Findings:

  • The temporal association and normal cardiac findings suggest sumatriptan may induce coronary vasospasm.

Related Experiment Videos

  • Coronary vasospasm is a probable mechanism for the myocardial infarction in this patient.
  • This case highlights a potential serious cardiovascular adverse event associated with sumatriptan.

    • Implications:

    • Clinicians should consider sumatriptan-induced coronary vasospasm in patients presenting with cardiac symptoms post-administration.
    • Further research is warranted to elucidate the cardiovascular risks of sumatriptan.
    • This finding may influence prescribing guidelines and patient counseling for sumatriptan.